Wird geladen...

Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes

Current therapies for metastatic ovarian carcinoma are based on surgical debulking followed by chemotherapy. After more than three decades implementing treatments that selectively target the tumor cell, the 5-year survival rate for metastatic ovarian cancer patients is still lower than 30%. Novel st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cubillos-Ruiz, Juan R., Rutkowski, Melanie, Conejo-Garcia, Jose R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3056209/
https://ncbi.nlm.nih.gov/pubmed/20023378
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!